From ancient remedies to cutting-edge pills, science is reshaping the answer to hair loss.
Is there really any hope for balding men? It’s a question which has echoed from ancient remedies to modern biotech labs—and the answer today is more nuanced than ever.
Hair loss, particularly male pattern baldness (androgenetic alopecia), is driven largely by genetics and hormones. The key culprit is dihydrotestosterone (DHT), a byproduct of testosterone which gradually shrinks hair follicles in men who are genetically sensitive to it. Over time, those follicles produce thinner, shorter hairs until they stop growing altogether.
RELATED: How Marijuana Can Heighten Intimacy With Your Partner
Humans have been trying to stop hair loss for centuries. Ancient Egyptians used mixtures of fats and herbs; in the 19th century, tonics and elixirs filled apothecaries. But modern medicine didn’t produce anything scientifically credible until the late 20th century.
Two treatments became the gold standard. Minoxidil—originally a blood pressure drug—was repurposed as a topical solution to stimulate hair growth. Finasteride, approved in 1997, works internally by blocking the enzyme converting testosterone into DHT.
These drugs remain the backbone of treatment today. Studies show finasteride can slow hair loss and even regrow hair in many men, with more than 85% seeing improvement over time. But there’s a catch: the effects only last as long as the medication is taken, and side effects—particularly sexual ones—have made some users hesitant.
A recent New York Times–reported trend has brought new attention to oral treatments, especially low-dose oral minoxidil. Once considered too risky due to cardiovascular side effects at higher doses, it’s now being prescribed in much smaller amounts for hair loss, with growing anecdotal and clinical support.
At the same time, experimental drugs are pushing the conversation further. One emerging therapy, ABS-201, is an antibody-based treatment designed using AI and currently in early human trials. Another, PP405, targets cellular metabolism to potentially “wake up” dormant hair follicles, with early trials showing promising density improvements in some patients.
And while not a pill, one of the most talked-about breakthroughs involves a topical acne drug, clascoterone, which blocks DHT directly at the scalp. In large clinical trials, it significantly increased hair counts over six to twelve months—hinting at a future with fewer systemic side effects.
RELATED: Marijuana MicroDosing Can Improve Mundane Tasks
Is there hope? The honest answer: yes—but with limits. Science has clearly moved beyond snake oil. Today’s treatments can slow, stop, and sometimes partially reverse hair loss. New therapies in development suggest the next decade could bring more targeted, effective options, possibly even ones regenerating dormant follicles rather than just preserving what remains.
But a true “cure”—a one-time fix that permanently restores a full head of hair—remains elusive. Most current and emerging treatments require ongoing use, and results vary widely depending on genetics, timing, and overall health.
The bottom line is balding is no longer a helpless condition, but it’s not fully conquered either. For now, the science offers management, not miracles—but for millions of men, it is already a meaningful shift.
